Publicacions en col·laboració amb investigadors/es de Hospital Clínico San Carlos de Madrid (14)

2024

  1. Practical use of new therapies for the management of dyslipidaemias. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 310-321

  2. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy

    REC: CardioClinics, Vol. 58, pp. S49-S54

2022

  1. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  2. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  3. Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach

    Future cardiology, Vol. 18, Núm. 9, pp. 743-754

  4. Selection of the best of 2021 in clinical cardiology and COVID-19

    REC: CardioClinics, Vol. 57, pp. S17-S22

2020

  1. Patients with a high cardiovascular risk and atrial fibrillation: the role of rivaroxaban

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 30-38

2019

  1. Lifestyle and cardiovascular risk factors in Spanish, Portuguese and Latin-American cardiologists. PREDICA survey

    REC: CardioClinics, Vol. 54, Núm. 1, pp. 17-26

2018

  1. Niveles óptimos de colesterol en los pacientes con dislipemia. Revisión sistemática de la evidencia

    Semergen: revista española de medicina de familia, Núm. 1, pp. 42-49

  2. Niveles óptimos de colesterol en los pacientes con dislipemia. Revisión sistemática de la evidencia

    Semergen, Vol. 44, Núm. 1, pp. 42-49

2016

  1. Cambios en los objetivos terapéuticos y grado de control de la hipertensión arterial: nuevas evidencias

    Hipertensión y riesgo vascular, Vol. 33, Núm. 2, pp. 63-68

2010

  1. Antihypertensive efficacy and tolerability oflercanidipine in daily clinical practice. The ELYPSE study

    Russian Journal of Cardiology, Vol. 84, Núm. 4, pp. 72-77